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PlasticityMetabolic dysfunction occurring after traumatic brain injury (TBI) is an important risk factor for the development
of psychiatric illness. In the present study, we utilized an omega-3 diet during early life as a metabolic precondi-
tioning to alter the course of TBI during adulthood. TBI animals under omega-3 deﬁciency were more prone to
alterations in energy homeostasis (adenosinemonophosphate-activated protein kinase; AMPK phosphorylation
and cytochrome C oxidase II; COII levels) and mitochondrial biogenesis (peroxisome proliferator-activated
receptor gamma coactivator 1-alpha; PGC-1α and mitochondrial transcription factor A; TFAM). A similar
response was found for brain-derived neurotrophic factor (BDNF) and its signaling through tropomyosin
receptor kinase B (TrkB). The results from in vitro studies showed that 7,8-dihydroxyﬂavone (7,8-DHF), a TrkB
receptor agonist, upregulates the levels of biogenesis activator PGC-1α, and CREB phosphorylation in neuroblas-
toma cells suggesting that BDNF–TrkB signaling is pivotal for engaging signals related to synaptic plasticity and
energymetabolism. The treatmentwith 7,8-DHF elevated themitochondrial respiratory capacity, which empha-
sizes the role of BDNF–TrkB signaling as mitochondrial bioenergetics stimulator. Omega-3 deﬁciency worsened
the effects of TBI on anxiety-like behavior and potentiated a reduction of anxiolytic neuropeptide Y1 receptor
(NPY1R). These results highlight the action of metabolic preconditioning for building long-term neuronal
resilience against TBI incurred during adulthood. Overall, the results emphasize the interactive action of
metabolic and plasticity signals for supporting neurological health.
© 2013 Published by Elsevier B.V.1. Introduction
The brain is a highly metabolic organ, such that disruptions of
metabolic homeostasis can have dramatic consequences for informa-
tion processing and cognitive function. Traumatic brain injury (TBI) is
followed by a state of brain energy crisis [1], which compromises neuro-
nal survival and long-term brain function. However, there is a paucity of
studies investigating how metabolic adaptations contribute to buildated protein kinase; BDNF, brain-
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les E. Young Drive South, Los
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vier B.V.a neuronal reserve for supporting long-term plasticity. Nutritional
imbalance during early life appears as a determinant factor for the risk
imposed by metabolic diseases later in life [2], and this concept
conforms to the basis for the postulate of “Metabolic Programming”.
Accordingly, we embarked in studies to investigate how nutrition
during early life could inﬂuence bioenergetics in the brain, which can
alter neuronal resilience in TBI during adulthood. The omega-3 polyun-
saturated fatty acid docosahexaenoic acid (DHA) is considered as an
essential nutrient for proper brain development and function; [3] how-
ever, its action onmetabolism is poorly understood. Herewe report that
omega-3 fatty acids support metabolic pathways involved in energy
homeostasis, which are fundamental for proper brain function under
homeostatic and injury conditions.
Patients suffering even mild concussive cerebral injury often exhibit
long-term cognitive and emotional disturbances, in spite of minimal
neurological damage [4,5]. In particular, depression and anxiety disor-
ders are the most prevalent sequel in the survivors of TBI [6]. Recent
clinical and experimental studies suggest that neuronal metabolic
abnormalities occurring after TBI are important instigators of neurolog-
ical and psychological aberrations [7,8]. An increasing line of research
emphasizes the potential of DHA protecting against psychiatric disor-
ders [9]. Accordingly, we have assessed the action of DHA onmolecular
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plasticity, and may determine the course of TBI.
Mitochondria are particularly susceptible to damage as they are the
major bioenergetics machinery and source of oxidative stress in cells.
Therefore, effective control ofmitochondrial bioenergetics and turnover
becomes critical for the maintenance of energy production, prevention
of oxidative stress and neuronal function. Multiple endogenous and
exogenous factors regulate mitochondrial biogenesis through peroxi-
some proliferator-activated receptor gamma coactivator-1alpha (PGC-
1α), which is a transcriptional regulator of various transcription factors,
including nuclear respiratory factors (NRFs). The NRFs activate the
mitochondrial transcription factor A (TFAM) that regulates mitochon-
drial DNA (mtDNA) transcription and replication [10]. Brain-derived
neurotrophic factor (BDNF), a neurotrophin classically recognized for
its role on plasticity andbehavior, likely plays a central role in the events
that link metabolism and synaptic plasticity. New studies indicate that
BDNF participates in a range of metabolic events, including glucose
utilization and energymanagement [11,12]. Accordingly, we conducted
studies using 7,8-dihydroxyﬂavone (7,8-DHF), a TrkB agonist, to
explore the role of BDNF signaling on the regulation of mitochondrial
function. This study provides crucial information to understand the
potential of diet to modulate the interaction between mitochondrial
homeostasis and synaptic plasticity as a mechanism that regulates the
capacity of the brain to resist TBI.
2. Materials and methods
2.1. Animals & experimental design
Female Sprague–Dawley rats (250–280 g) were obtained from
Charles River Laboratories (Wilmington, MA, USA) on the 3rd day of
pregnancy. The animals were kept in polyacrylic cages under standard
housing condition (22–24 °C) with 12 h light/dark cycle in two dietary
groups. Pregnant female rats were fed an either omega-3 fatty acid
adequate (n−3 diet) or omega-3 fatty acid deﬁcient (n−3 def) diet
through gestation and lactation. The two custom diets used were
based on the composition of the American Institute of Nutrition diet
(AIN-93G) and prepared commercially (Dyets Inc., PA, USA) as previ-
ously described [13]. Both diets had the same basal macronutrients,
vitamins, minerals, and basal fats (hydrogenated coconut and safﬂower
oils) (Table 1). The only difference between two diets was the amount
of n−3 fatty acids, which was achieved by adding 0.5% of ﬂaxseed oilTable 1
Composition of experimental diets.
Ingredient Amount (g/100 g diet)
n−3 adq n−3 def






Salt-mineral mix 3.5 3.5
Vitamin mix 1 1
L-cystine 0.3 0.3
Choline bitartrate 0.25 0.25
TBHQ 0.002 0.002
Fat sources:
Hydrogenated coconut oil 7.45 8.1
Safﬂower oil 1.77 1.9
Flaxseed oil 0.48 –
DHAa 1.2 –
EPAa 0.24 –
Other n3 sa 0.1 –
Note: Dashes indicate that component was not added.
a Procured fromNordic Naturals Inc., CA, USA ProDHA capsule that contains 45% (w/w)
DHA, 9% (w/w) EPA and 4% (w/w) other n−3 s.(source of 18:3n−3; α-linolenic acid, ALA) and 2.7% of ProDHA oil
(Nordic Naturals, Inc., CA, USA) to the n−3 diet. The ﬁnal concentration
of DHA, EPA and other n−3 fatty acids in n−3 diet was 1.2%, 0.24% and
0.1% of total n−3 diet respectively. The diets were provided in powder
in a bowl and animals had free access to food and water.
The study consists of a total of 16 litters (8/diet group), and only
male offspring were included in the experimental groups. At weaning
on postnatal day (PND) 21, the offspring were fed on the same diet as
their dams and randomly divided into four experimental groups in a
way that each offspring within an experimental group (n = 8) was
chosen from a different litter. The male offspring from dams fed an
omega-3 adequate diet were split into (1) sham (n−3 diet/Sham)
and (2) ﬂuid percussion injury (n−3 diet/FPI) groups. The offspring
from dams fed an omega-3 deﬁcient diet were also split into (3) sham
(n−3 def/Sham) and (4) ﬂuid percussion injury (n−3 def/FPI) groups.
At 17 weeks of age, the offspring fromeachdietary groupwere subjected
to either sham or ﬂuid percussion injury (FPI). To assess the anxiety-like
behavior, the offspringwere subjected to the elevated plusmaze (EPM)
test after 1 week of injury (i.e. at 18 weeks of age) and were killed
immediately by decapitation after the behavioral test. Fresh brain
tissues were dissected out, frozen in dry ice and stored at −70 °C
until use. Brain tissues were shared from the same animals for fatty
acid and immunoblotting analysis. All experiments were performed in
accordance with the United States National Institutes of Health Guide
for the Care and Use of Laboratory Animals, and were approved by the
University of California at Los Angeles Chancellor's Animal Research
Committee.
2.2. Fluid percussion injury
The injury was performed as previously described [14]. In brief, the
animals were anesthetized by using a Laboratory Animal Anesthesia
System (VetEquip Inc., CA, USA) that provides a mixture of isoﬂurane
and oxygen. The animals were maintained in a deep anesthetic state
during surgery with 2–5% isoﬂurane mixed with 100% O2 at a ﬂow
rate of 0.4 l/min via nose cone. With the aid of a microscope (Wild,
Heerbrugg, Switzerland) a 3.0-mm-diameter craniotomy was made
over the left parietal cortex, 3.0 mm posterior to bregma and 6.0 mm
lateral (left) to the midline with a high-speed drill (Dremel, WI, USA).
A plastic injury cap was placed over the craniotomy with silicone adhe-
sive and dental cement.When the dental cement hardened, the capwas
ﬁlled with 0.9% saline solution. Anesthesia was discontinued and the
injury cap was attached to the ﬂuid percussion device. At the ﬁrst sign
of hind-limb withdrawal to a paw pinch, a mild ﬂuid percussion pulse
(1.5 atm) was administered to the epidural space. Immediately upon
responding to a paw pinch, anesthesia was restored and the skull was
sutured. Neomycin was applied on the suture and the rats were placed
in a heated recovery chamber before being returned to their cages.
Sham animals underwent an identical preparation with the exception
of the lesion.
2.3. Elevated plus maze
After 1 week of FPI, the rats were subjected to elevated plus maze
(EPM) test [15]. Brieﬂy, the EPM apparatus made of laminated wood
consisted of 2 opposing open arms (10 × 50 cm) and 2 opposing closed
arms (10 × 50 cmwith 30 cm high walls). Themazewas placed 60 cm
above the ﬂoor. White curtains surrounded the maze and behavior was
recorded by an overhead video camera over a period of 5 min. Each rat
was placed in the middle of the maze facing the open arm that faced
away from the experimenter. The time spent and the number of entries
in each arm were measured using AnyMaze video tracking software
(San Diego Instruments, CA, USA). The total number of times the rats
entered in the arms during the EPM test were calculated to account
for differences in general motor activity in the maze.
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Fatty acidsweremeasured by gas chromatography in cortical tissues
and total lipids were extracted according to published methods [16].
Brieﬂy, frozen brains were homogenized in chloroform/methanol
(2:1 vol/vol), containing 50 μg/ml of butylated hydroxytoluene to pre-
vent lipid oxidation during the procedure. Tricosanoic acid methylester
(C23:0) was used as an internal standard. Tissues were grounded to
powder under liquid nitrogen and subjected to extraction of total lipids.
Fatty acid methylation was done by heating at 90 °C for 1 h under 14%
(w/v) boron triﬂuoride–methanol reagent.
Extracted lipids were analyzed on Clarus 500 gas chromatograph
(GC; PerkinElmer, MA, USA) equipped with a built-in Autosampler
and ﬂame ionization detector (FID). An Elite-WAX column (60 m,
0.32-mm internal diameter) was used, with hydrogen as the carrier
gas. GC oven temperature was initially held at 140 °C for 2 min and
raised with a gradient of 5 °C min−1 until 250 °C and held for 10 min.
The total run time is 34 min. The injector and detector weremaintained
at 250 °C and 300 °C, respectively. A 1 μl sample of fatty acid methyl
esters (FAME) was injected in split injection mode with a 100:1 split
ratio. Peaks of resolved fatty acid methyl esters were identiﬁed and
quantiﬁed by comparison with standards (Supelco 37-component
FAME Mix).
2.5. Immunoblotting
The frontal cortex tissues were homogenized in a lysis buffer
containing 137 mMNaCl, 20 mMTris–HCl pH 8.0, 1%NP40, 10% glycerol,
1 mM phenylmethylsulfonylﬂuoride (PMSF), 10 μg/ml aprotinin,
0.1 mMbenzethonium chloride, 0.5 mMsodiumvanadate. The homog-
enateswere then centrifuged, the supernatants were collected and total
protein concentration was determined according to MicroBCA proce-
dure (Pierce, IL, USA), using bovine serum albumin (BSA) as standard.
Brieﬂy, protein samples were separated by electrophoresis on a 10%
polyacrylamide gel and electrotransferred to a PVDF membrane
(Millipore, MA, USA). Non-speciﬁc binding sites were blocked in
Tris–buffered saline (TBS), pH 7.6, containing 5% non-fat drymilk. Mem-
branes were rinsed in buffer (0.05% Tween-20 in TBS) and then
incubated with anti-actin or anti-BDNF, anti-pTrkB, anti-TrkB, anti-
AMPK, anti-cytochrome c oxidase II, anti-mtTFA (TFAM), anti-SOD-2
4HNE(1:500; Santa Cruz Biotechnology, CA, USA), anti-PGC-1α, anti-
pCREB, anti-CREB (1:1000, Millipore, MA, USA), anti-pAMPK (1:1000;
Cell signaling technology, MA, USA), anti-NPY1R (1:1000; Alpha Diag-
nostic Intl. Inc., TX, USA) followed by anti-rabbit or anti-goat or anti-
mouse IgG horseradish peroxidase-conjugate (1:10,000; Santa Cruz Bio-
technology, CA, USA). After rinsing with buffer, the immunocomplexes
were visualized by chemiluminescence using the ECL kit (Amersham
Pharmacia Biotech Inc., NJ, USA) according to the manufacturer's
instructions. The ﬁlm signals were digitally scanned and then quantiﬁed
using ImageJ software. Actin was used as an internal control forWestern
blot such that data were standardized according to actin values.
2.6. In vitro experiments
2.6.1. Cell culture
Neuro-2a cells (mouse neuroblastoma cell line from American Type
Culture Collection; ATCC, VA, USA) were maintained as monolayer
cultures in Dulbecco's modiﬁed Eagle medium (DMEM) (Gibco by
Life Technologies Inc., NY, USA) supplemented with 10% (v/v) fetal
bovine serum (Gibco by Life Technologies Inc., NY, USA), penicillin
(100 units/ml) and streptomycin (100 μg/ml) at 37 °C, in a humidiﬁed
atmosphere containing 95% air and 5% CO2. Cells were treated with
dimethyl sulfoxide (DMSO; with a ﬁnal concentration of 0.01%) or
100, 200 and 400 nM of 7,8-dihydroxyﬂavone (7,8-DHF) for 2 h. The
doses and time of 7,8-DHF treatment were chosen on the basis of
optimal activation of TrkB receptor as demonstrated in previousin vitro studies [17]. After 2 h, cell lysates were prepared in 1× RIPA
lysis buffer containing protease inhibitors for immunoblotting. Total
protein concentration was determined according to MicroBCA proce-
dure (Pierce, IL, USA), using bovine serum albumin (BSA) as standard
and immunoblotting was performed as described above.
2.6.2. Immunocytochemistry
N2a cells were plated onto 4-chamber slides for immunocytochem-
ical analysis. Cells were cultured as described above and 7,8-DHF was
added to the wells at a concentration of 200 nM. After 2 h incubation
with 7,8-DHF, cells were ﬁxed with 4% paraformaldehyde for 10 min,
washed with PBS and incubated for 1 h at room temperature with 2%
BSA in Tris-buffered saline containing 0.2% Triton-X-100 (TBST) to
inhibit non-speciﬁc binding. Primary antibodies (CREB and PGC-1α
from Millipore, MA, USA), diluted in 1% bovine serum albumin (BSA)/
TBST, were added to the cells and incubated overnight at 4 °C in a
humidiﬁed chamber. Cells were washed several times with PBS and
were incubated with appropriate dilutions of ﬂuorescent mouse
or rabbit secondary antibodies (FITC; 1:1000, Cy3; 1:4000; Jackson
ImmunoResearch Laboratories Inc., PA, USA) for 1 h at room tempera-
ture. Slides were washed in PBS and mounted using aquamount.
Negative controls were performed by omission of the primary antibody.
The staining was visualized under Zeiss microscope (Zeiss Imager.Z1)
using the Axiovision 4.6 software.
2.6.3. Mitochondrial bioenergetics analysis
Mitochondrial bioenergetics functions were measured using
an XF24 Extracellular Flux Analyzer (Seahorse Bioscience, MA, USA).
One day before analysis, N2a cells were seeded in V7 plates (Seahorse
Bioscience) at 4 × 104 cells/well and cultured as described above.
Cells were incubated with 200 nM of 7,8-DHF and cellular respiration
wasmeasured after 4, 8 and 12 h treatment. Prior to themeasurements,
the culture medium was changed to unbuffered complete DMEM as
described by Wu et al. [18]. Mixing, waiting and measure times were
3, 2 and 3 min, respectively. To assess mitochondrial functions, oxygen
consumption rate (OCR) was measured in basal condition and after
sequential injection of 0.75 μM oligomycin, 0.25 μM carbonyl cyanide-
p-triﬂuoromethoxyphenylhydrazone (FCCP), and a mixture of 0.75 μM
rotenone-myxothiazol. The ATP synthase inhibitor oligomycin allows
the detection of ATP-linked respiration by decreasing OCR, thus indicat-
ing the extent of respiration to which cells are using mitochondria to
generate ATP. The uncoupler FCCP reveals maximal mitochondrial
respiratory capacity, while rotenone–myxothiazol blocksmitochondrial
respiration at complexes I and III.
2.7. Statistical analysis
The results are represented as mean ± standard error of the mean
(SEM). Protein results are expressed as percentage of n−3 diet group
for in vivo experiments and statistical analysis was performed by two-
way analysis of variance (ANOVA; diet vs. injury). Post-hoc analyses
were conducted using Bonferroni's multiple comparison tests to deter-
mine the signiﬁcanceof difference amongvarious groups. For in vitro ex-
periments, protein results are expressed as percentage of control group
and data was analyzed by one-way ANOVA followed by Bonferroni's
multiple comparison tests. The p-value b 0.05 was considered as statis-
tically signiﬁcant. Pearson correlation analysis was performed on indi-
vidual samples to evaluate the association between variables.
3. Results
3.1. Brain trauma affected metabolic proteins primarily in n−3 fatty acid
deﬁcient animals
We have evaluated the vulnerability imposed by early nutrition on
the effects of TBI in cortical tissues by focusing on the role of proteins
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ANOVA analysis (diet vs. injury) showed a signiﬁcant effect of diet
(F1,28 = 4.611, p b 0.05), injury (F1,28 = 6.904, p b 0.05) and an inter-
action between diet vs. injury (F1,28 = 4.715, p b 0.05) for AMPK phos-
phorylation. The Bonferroni post-hoc test for multiple comparisons
showed that the n−3 deﬁciency was a factor for the action of TBI, as
FPI decreased AMPK phosphorylation only under n−3 deﬁciency
(n−3 def/FPI vs. n−3 def/Sham group; p b 0.01). In turn, the n−3
diet appeared to protect the brain against the effects of the injury as
FPI did not alter AMPK phosphorylation levels under the n−3 diet
condition (n−3 diet/FPI vs. n−3 diet/Sham, p N 0.05; Fig. 1A).
We assessed the levels of COII, a mitochondrial protein, which pro-
vides an index of mitochondrial function/mass and plays an important
role in mitochondrial oxidative phosphorylation (OXPHOS). Two-way
ANOVA analysis revealed a signiﬁcant effect of diet (F1,28 = 9.069,
p b 0.01) and its interaction with injury (F1,28 = 4.244, p b 0.05) for
COII level. The post-hoc analysis showed that COII levels were reduced
under the n−3 deﬁciency (n−3 def/FPI vs. n−3 def/Sham group,
p b 0.05), while the adequate levels of dietary n−3 fatty acid main-
tained the levels of COII after TBI (n−3 diet/FPI vs. n−3 diet/Sham,
p N 0.05; Fig. 1B). The positive correlation between percentage time
spent in the open arms and level of COII (r = 0.538, p b 0.01) suggests
that anxiety-like behavior tested in the elevated plus maze may rely on
the levels of mitochondrial proteins (Fig. 1C).
We assessed a possible association between AMPK action and regu-
lation of the mitochondrial PGC-1α, and found that the AMPK phos-
phorylation varied in proportion to the level of PGC-1α (r = 0.514,
p b 0.01; Fig. 1D).Fig. 1. (A) Phosphorylation of AMPK, (B) levels of COII protein, (C) correlation analysis of COII
phosphorylation with levels of PGC-1α in groups fed with either n−3 fatty acid (n−3 diet) or
injury (FPI). Data are expressed as percentage of n−3 diet group (mean ± SEM). #p b 0.05
followed by post-hoc test with Bonferroni's comparisons.3.2. Brain trauma affected molecules associated with mitochondrial
function primarily in n−3 fatty acid deﬁcient animals
We examined the levels of PGC-1α, which is amember of a family of
transcription co-activators that plays a central role in the regulation of
cellular energy metabolism. The signiﬁcant effect of diet (F1,28 =
72.082, p b 0.01) and injury (F1,28 = 4.723, p b 0.05) as well as a
signiﬁcant interaction between diet vs. injury (F1,28 = 6.733, p b 0.05)
were observed on PGC-1α levels by two-way ANOVA. The Bonferroni
post-hoc test showed the effect of TBI on PGC-1α only in the state of
n−3 deﬁciency (n−3 def/FPI vs. n−3 def/Sham, p b 0.01). The prior
exposure of n−3 diet was able to counteract the effect of brain injury
on levels of PGC-1α, as the PGC-1α levels remained similar in both of
the n−3 diet groups (n−3 diet/FPI vs. n−3 diet/Sham, p N 0.05). We
observed that n−3 deﬁciency resulted in a decreased expression of
PGC-1α in sham animals (n−3 diet/Sham vs. n−3 def/Sham,
p b 0.01; Fig. 2A).
The level of PGC-1α varied in proportion to the phosphorylation of
cyclic AMP response element binding protein (CREB) (r = 0.621,
p b 0.01), suggesting that association of CREB with co-activator PGC-
1α (Fig. 2B).We also observed that the levels of PGC-1αwere positively
correlated with the percentage of time spent in the open arms of the
elevated plus maze test (r = 0.662, p b 0.01) suggesting that an
increased PGC-1αmay contribute to decrease in anxiety-like behavior
(Fig. 2C).
Several studies have been suggested that the PGC-1αworks in close
association with the reactive oxygen species (ROS)-detoxifying capacity
of cells [19]. Reactive oxygen species (ROS), a byproduct ofmitochondrialwith percentage of time spent in open arms of EPM and (D) correlation analysis of AMPK
n−3 fatty acid deﬁcient (n−3 def) diet and subjected to either sham or ﬂuid percussion
vs. n−3 diet/Sham, ⁎p b 0.05, **p b 0.01 vs. n−3 def/Sham group; ANOVA (two-way)
Fig. 2. (A) Protein level of PGC-1α, (B) correlation analysis of CREB phosphorylation with levels of PGC-1α, (C) correlation analysis of PGC-1αwith percentage of time spent in open arms of
EPM, (D) levels of SOD2, (E) levels of 4HNE, (F) correlation analysis of 4HNEwith percentage of time spent in open armsof EPMand (G) levels of TFAM in groups fedwith either n−3 fatty acid
(n−3 diet) or n−3 fatty acid deﬁcient (n−3 def) diet and subjected to either sham or ﬂuid percussion injury (FPI). Data are expressed as percentage of n−3 diet group (mean ± SEM).
#p b 0.05, ##p b 0.01 vs. n−3 diet/Sham, ⁎p b 0.05 vs. their respective n−3 diet/Shamor n−3 def/Shamgroup; ANOVA (two-way) followed by post-hoc testwith Bonferroni's comparisons.
539R. Agrawal et al. / Biochimica et Biophysica Acta 1842 (2014) 535–546electron transport chain, leads to oxidative damage by increasing lipid
peroxidation of unsaturated fatty acids. Therefore, we assessed the
levels of mitochondrial protein superoxide dismutase 2 (SOD2), anantioxidant and levels of 4-hydroxynonenal (4HNE), a marker of lipid
peroxidation, to have a comprehensive view of the effects of diet and
TBI on oxidative stress. For the levels of SOD2, two-wayANOVA analysis
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(F1,28 = 8.260, p b 0.01). TBI was able to reduce the level of SOD2, only
in the absence of n−3 in diet (n−3 def/FPI vs. n−3 def/Sham,
p b 0.01). Pre-exposure to n−3 fatty acid prevented the effects of TBI
on SOD2 levels as there was no effect observed after FPI under n−3
diet condition (n−3 diet/FPI vs. n−3 diet/Sham, p N 0.05). Exposure
to dietary n−3 fatty acid deﬁciency resulted in a signiﬁcant decrease
in the levels of SOD2 (n−3 def/Sham vs. n−3 diet/Sham, p b 0.05;
Fig. 2D). With regard to the levels of 4HNE, a signiﬁcant effect of diet
(F1,28 = 12.432 p b 0.01) and injury (F1,28 = 5.393 p b 0.05) as well
as their interaction (F1,28 = 8.189 p b 0.01) was observed by ANOVA
(two-way) analysis. TBI elevated the levels of 4HNE under n−3
deﬁciency (n−3 def/FPI vs. n−3 def/Sham, p b 0.01); however, the
prior exposure of n−3 diet was able to counteract the effect of TBI on
4HNE levels (n−3 diet/FPI vs. n−3 diet/Sham, p N 0.05). Omega-3
fatty acid deﬁciency had no effect on 4HNE levels in sham animals
(n−3 def/Sham vs. n−3 diet/Sham, p N 0.05; Fig. 2E). The levels of
4HNE were negatively correlated with percentage of time spent in the
open arms of elevated plus maze test (r = −0.737, p b 0.01) suggest-
ing that an increased lipid peroxidation may contribute to increase
anxiety-like behavior (Fig. 2F).
Further, we assessed the mitochondrial transcription factor TFAM,
which is a key activator of mitochondrial transcription and mitochon-
drial genome replication. A signiﬁcant effect of diet (F1,28 = 4.584,
p b 0.05) and an interaction between diet vs. injury (F1,28 = 5.856
p b 0.05) were observed for the levels of TFAM by two-way ANOVA.Fig. 3. (A) Protein level of BDNF, (B) TrkB phosphorylation, (C) phosphorylation of CREB and (
with either n−3 fatty acid (n−3 diet) or n−3 fatty acid deﬁcient (n−3 def) diet and subjecte
diet group (mean ± SEM). #p b 0.05, ##p b 0.01 vs. n−3 diet/Sham, ⁎p b 0.05, ⁎⁎p b 0.01 v
comparisons.The post-hoc test performed for multiple comparisons showed that
TBI increased levels of TFAM in animals fed an n−3 diet (n−3 diet/
FPI vs. n−3 diet/Sham, p b 0.05). TBI had no effects on TFAM levels in
animals exposed to the n−3 deﬁcient diet (n−3 def/FPI vs. n−3 def/
Sham, p N 0.05; Fig. 2G).
3.3. BDNF signaling systems
BDNF signaling has emerged as a key player in several psychiatric
conditions such as depression and anxiety disorders [20,21]. To assess
the changes in BDNF signaling, we measured the phosphorylation
level of tropomyosin receptor kinase B (TrkB) and its downstream
effector CREB in groups subjected to TBI with or without n−3 fatty
acid in diet. Two-way ANOVA analysis showed a signiﬁcant effect of
diet (F1,28 = 12.569 p b 0.05) and injury (F1,28 = 10.549 p b 0.01), as
well as, a signiﬁcant interaction between diet and injury (F1,28 =
4.958 p b 0.05) was observed for BDNF levels. Bonferroni post-hoc
test showed that FPI reduced the levels of BDNF in animals exposed to
n−3 deﬁciency (n−3 def/FPI vs. n−3 def/Sham, p b 0.01), while
n−3 fatty acid prior to the FPI prevented this reduction (n−3 diet/
FPI vs. n−3 diet/Sham, p N 0.05; Fig. 3A). With regard to phosphoryla-
tion of TrkB, the signiﬁcant effects of diet (F1,28 = 58.763 p b 0.01) and
its interaction with injury (F1,28 = 6.641 p b 0.05) was observed by
ANOVA (two-way) analysis. TBI reduced TrkB phosphorylation under
n−3 deﬁciency (n−3 def/FPI vs. n−3 def/Sham, p b 0.01); however,
TBI had no effects on TrkB receptor in the presence of n−3 fatty acidD) correlation analysis of BDNF with percentage of time spent in open arms, in groups fed
d to either sham or ﬂuid percussion injury (FPI). Data are expressed as percentage of n−3
s. n−3 def/Sham group; ANOVA (two-way) followed by post-hoc test with Bonferroni's
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ciency of n−3 reduced levels of TrkB phosphorylation in sham animals
(n−3 def/Sham vs. n−3 diet/Sham, p b 0.01; Fig. 3B). BDNF affects
neuronal plasticity through the activation of CREB. The phosphorylation
of CREB changed signiﬁcantly with diet (F1,28 = 31.821 p b 0.01) and
injury (F1,28 = 7.867 p b 0.01) by ANOVA (two-way) analysis. We
found that FPI reduced CREB phosphorylation in the n−3 deﬁcient
group (n−3 def/FPI vs. n−3 def/Sham, p b 0.01); however, FPI
did not affect the phosphorylation of CREB in the presence of n−3
diet (n−3 diet/FPI vs. n−3 diet/Sham, p N 0.05). Exposure to dietary
n−3 fatty acid deﬁciency resulted in a signiﬁcant decrease in phos-
phorylation of CREB (n−3 def/Sham vs. n−3 diet/Sham, p b 0.01;
Fig. 3C). There was a positive correlation between BDNF and percentage
time spent in the open arms (r = 0.546, p b 0.01), suggesting an asso-
ciation between BDNF signaling and performance in the EPM (Fig. 3D).3.4. Preponderant effects of brain trauma on anxiety-like behavior in n−3
fatty acid deﬁciency
We corroborated the effects of TBI and dietary n−3 fatty acid
interventions on anxiety-like behavior and related molecular markers.
Two-way ANOVA analysis showed a signiﬁcant effect of diet (F1,28 =
44.253 p b 0.01) and injury (F1,28 = 6.077 p b 0.05) for percentage of
time spent in the open arms in elevated plus maze. The post-hoc
analysis showed a marked reduction in the percentage of time spent
in the open arms after TBI in dietary n−3 fatty acid deﬁcient condition
(n−3 def/FPI vs. n−3 def/Sham, p b 0.01). However, FPI had no effect
on these variables after n−3 feeding (n−3 diet/FPI vs. n−3 diet/Sham,
p N 0.05). The dietary n−3 fatty acid deﬁciency also decreased the per-
centage of time spent in the open arms in sham animals (n−3 def/
Sham vs. n−3 diet/Sham, p b 0.01; Fig. 4A). The generalmotor activity,
as measured by the total number of entries during the EPM test was
similar among all the groups (data not shown) suggesting that the
changes in anxiety-like behavior were not due to changes in motor
activity.Fig. 4. (A) Percentage of time spent in open arms, (B) correlation analysis of NPY1R with perce
fatty acid (n−3 diet) or n−3 fatty acid deﬁcient (n−3 def) diet and subjected to either sha
(mean ± SEM). #p b 0.05, ##p b 0.01 vs. n−3 diet/Sham, ⁎p b 0.05 vs. n-3 def/Sham group; AWe assessed levels of neuropeptide Y1 receptor (NPY-1R) based on
its involvement in anxiety and depression-like behavior [22]. There was
a positive correlation between NPY1R levels and the percentage time
spent in the open arms (r = 0.616, p b 0.01) in EPM test (Fig. 4B).
With regard to the levels of NPY1R, the signiﬁcant effects of diet
(F1,28 = 41.670 p b 0.01) and injury (F1,28 = 8.298 p b 0.01) as well
as a signiﬁcant interaction between diet vs. injury (F1,28 = 4.468
p b 0.05) were observed by two-way ANOVA. TBI reduced NPY-1R
levels under dietary n−3 deﬁciency (n−3 def/FPI vs. n−3 def/Sham,
p b 0.01). TBI had no effects in these variable under n−3 dietary condi-
tion (n−3 diet/FPI vs. n−3 diet/Sham, p N 0.05), which indicates that
pre-exposure to dietary n−3 fatty acid provides resistance to cope
with the effects of TBI. The dietary deﬁciency of n−3 fatty acid resulted
in lower levels of NPY1R in sham animals (n−3 def/Shamvs. n−3 diet/
Sham, p b 0.01; Fig. 4C).
3.5. Brain DHA contents
To conﬁrm accretion of n−3 fatty acid in the brain following the
diet, we measured the levels of DHA by using gas chromatography as
shown in Fig. 5. Signiﬁcant diet (F1,28 = 1169.98 p b 0.01) and injury
(F1,28 = 5.462 p b 0.05) effects were found for the levels of DHA by
two-way ANOVA analysis. The n−3 deﬁciency resulted in signiﬁcant
lower levels of DHA as analyzed by Bonferroni post-hoc test (n−3
def/Sham vs. n−3 diet/Sham, p b 0.01). TBI did not cause signiﬁcant
changes in DHA among n−3 diet or deﬁcient groups (n−3 diet/FPI
vs. n−3 diet/Shamp N 0.05; n−3 def/FPI vs. n−3 def/Sham, p N 0.05).
3.6. Activation of BDNF–TrkB signaling recruits metabolic proteins
Several lines of evidence point to the idea that BDNF is involved in
energy metabolism. We utilized the TrkB agonist 7,8-dihydroxyﬂavone
(7,8-DHF) to stimulate TrkB signaling pathway in mouse Neuro-2a
(N2a)-neuroblastoma cells. The exposure of 7,8-DHF for 2 h, stimulated
the phosphorylation of TrkB and its downstream effector CREB in a dose
dependent manner (100–400 nM; p b 0.05; Fig. 6A & B). The effect ofntage of time spent in open arms and (C) levels of NPY1R in groups fed with either n−3
m or ﬂuid percussion injury (FPI). Data are expressed as percentage of n−3 diet group
NOVA (two-way) followed by post-hoc test with Bonferroni's comparisons.
Fig. 5. Levels of docosahexaenoic acid (DHA; C22:6n−3) in groups fed with either n−3
fatty acid diet (n−3 diet) or n−3 fatty acid deﬁcient diet (n−3 def) and subjected to
either sham or ﬂuid percussion injury (FPI). Data are expressed as mg/g tissue (mean ±
SEM). ##p b 0.01 vs. n−3 diet/Sham group; ANOVA (two-way) followed by post-hoc
test with Bonferroni's comparisons.
Fig. 6.Phosphorylation of (A) TrkB (B) CREB and (C) levels of PGC-1α inNeuro-2a (N2a)-neurob
Data are expressed as percentage of control group (mean ± SEM) of four independent experi
with Bonferroni's comparisons. Immunoﬂuorescence staining of (D) PGC-1α (FITC) and CREB (C
images reveals the co-localization of PGC-1α and CREB in N2a cells (green for PGC-1α, red for
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which indicates that the activation of BDNF–TrkB signaling recruits
metabolic signals (p b 0.05; Fig. 6C). Furthermore, we assessed the
phenotypic expression of CREB and PGC-1α by immunocytochemical
analysis, and found that they co-localized in the same cells of the N2a
cell line. We observed a qualitative increase in the staining intensity
of CREB/PGC-1α co-localization after 2 h of 7,8-DHF treatment
(200 nM), which suggests that BDNF receptor activation recruits plas-
ticity and metabolic molecules in the same cell (Fig. 6D).
3.7. BDNF–TrkB signaling improves mitochondrial functions
To assess mitochondrial functions, we measured cellular respiration
in N2a cells with a XF24 Extracellular Flux Analyzer. Oxygen consump-
tion rate (OCR) wasmeasured in real time under basal condition and inlastoma cells treatedwith 100, 200 and 400 nMof 7,8-dihydroxyﬂavone (7,8-DHF) for 2 h.
ments. ⁎p b 0.05, ⁎⁎p b 0.01 vs. VEH group; ANOVA (one-way) followed by post-hoc test
y3) inN2a cells treatedwith 200 nMof 7,8-DHF for 2 h. Fluorescent immunocytochemical
CREB and yellow for co-stained cells, scale bar: 20 μm).
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(Fig. 7A). The ATP synthase inhibitor oligomycin was used to measure
ATP production-associated respiration. According to our results, the
treatment with 7,8-DHF (200 nM, 4–12 h) was not able to induce
changes in ATP-linked respiration (p N 0.05; Fig. 7B). Next, the uncou-
pler FCCP was used to determine the maximal OCR of the cells. The
FCCP-induced OCR represents themitochondrial reserve or spare respi-
ratory capacity of the cells, which is a strong indicator of mitochondrial
functions that may not be apparent under basal conditions. In response
to FCCP, the treatment of 7,8-DHF (200 nM) for 4 h was not effective to
induce any changes in OCR levels (data not shown). However, OCR was
higher after 8 and 12 h of 7,8-DHF (200 nM) treatment (p b 0.05;
Fig. 7B), indicating that the activation of BDNF–TrkB signaling enhances
themitochondrial reserve capacity of cells, thereby improvingmitochon-
drial function.
4. Discussion
We have found that consumption of an n−3 diet during early life
inﬂuences the capacity of the adult brain to resist the effects of TBI.
These effects were deeply associated with alterations in molecules
related to energy homeostasis such as nuclear (PGC-1α, TFAM) and
mitochondrial proteins (COII, SOD2) that play a key role on mitochon-
drial biogenesis, and control of cell oxidative damage. A highlight of
the results was the powerful action played by the BDNF receptor TrkB
agonist, 7,8-DHF on the regulation of mitochondrial bioenergetics, bio-
genesis activator PGC-1α and CREB phosphorylation, which emphasize
an association between plasticity and control of energy homeostasis.
These events can be crucial to maintain neuronal function following
TBI, when energy homeostasis is compromised. Our results also indicate
that anxiety-like behavior alterations engage elements related to mito-
chondrial biogenesis. Given the crucial role of metabolism on brain
plasticity and function, adequate n−3 ingestion particularly during
early life seems critical for fostering the plasticity necessary to abate
the effects of brain insults during adulthood.
4.1. Effects of TBI and diet on molecular systems related to energy
management
Clinical and experimental studies have documented the sequel
of mild concussion on brain metabolic markers after 1 week of mild
TBI [7,23]. We found that TBI, under dietary n−3 fatty acid deﬁciency,
compromised molecular systems important for the maintenance of
energy homeostasis such as AMPK phosphorylation. AMPK is a serine–
threonine kinase, which has the ability to sense the AMP/ATP ratio
and activate or inhibit the appropriate molecules to re-establish the
proper energy balance of the cell. Once activated, AMPK switches onFig. 7.Mitochondrial bioenergetics analysis in Neuro-2a (N2a)-neuroblastoma cells treatedwith
(OCR) was measured with an XF24 Extracellular Flux Analyzer before and after the sequent
production was calculated as response to the oligomycin, while maximal mitochondrial respira
as percentage of basal OCR (mean ± SEM) of six independent experiments. ⁎p b 0.05 vs. VEHcatabolic pathways to produce ATP while simultaneously shutting
down energy-consuming anabolic processes. This is achieved, in part,
via activation of PGC-1αwhose activity is regulated both by its expres-
sion level and by post-translational modiﬁcations involving AMPK-
directed phosphorylation [24] and sirtuin-regulated deacetylation
[25]. In our results, the presence of n−3 appeared to normalize energy
homeostasis probably by promoting conservation of ATP as evidenced
by no changes in AMPK phosphorylation in n−3 diet group with or
without TBI. The positive correlation between AMPK phosphorylation
and PGC-1α levels appears to support the above discussed association
between PGC-1α and AMPK functions. The occurrence of TBI under
dietary n−3 deﬁciency compromised molecular system involved in
energy balance as evidenced by a decrease in the activational state of
AMPK and the levels of PGC-1α.
We also observed a signiﬁcant decline in COII levels after TBI with
dietary n−3 fatty acid deﬁciency, which is likely associated withmeta-
bolic dysfunction. COII is a protein subunit of the terminal and highly
regulated enzyme complex IV of the electron transport chain in mito-
chondria [26]. COII plays a key role in controlling ATP production as it
helps to establish a transmembrane difference of proton electrochemical
potential in the electron transport chain of mitochondria. The presence
of n−3 in diet prevented the changes in the COII level. The results
showing that COII levels changed according to the times spent in the
open arms of the EPM provides an indication on how mitochondrial
activity can inﬂuence the anxiety-like behavior, and other neuropsychi-
atric disorders, as discussed below.
4.2. Mitochondrial homeostasis vs. neuronal plasticity
Mitochondria are particularly susceptible to damage as they are the
main bioenergetic machinery and the source of oxidative stress in cells.
Therefore, effective control of mitochondrial biogenesis and turnover
becomes critical for the maintenance of energy homeostasis and pre-
vention of oxidative stress. Our results show that diet and TBI inﬂuence
mitochondrial proteins important for maintaining neuronal plasticity
via activation of transcription regulators. In particular, PGC-1α is a
co-transcriptional regulator that activates various transcription factors,
including nuclear respiratory factors (NRFs). In turn, the NRFs activate
the mitochondrial transcription factor TFAM, which stimulates mtDNA
transcription. PGC-1α is a potent coactivator of a plethora of transcrip-
tion factors that inﬂuence whole-body energy expenditure, and is an
important mediator of several factors involved in mitochondrial
homeostasis such as AMPK. Therefore, the fact that TBI decreases PGC-
1α under n−3 fatty acid deﬁciency implies that the lack of n−3 predis-
poses the brain to the effects of TBI. The results showing that TBI
increased the level of TFAM only under dietary n−3 condition, empha-
sizes the role of n−3 fatty acids to maintain a homeostatic balance200 nMof 7,8-dihydroxyﬂavone (7,8-DHF) for 8 and 12 h. (A) Oxygen consumption rate
ial injection of oligomycin, FCCP and rotenone/myxothiazol. (B) Respiration due to ATP
tory capacity was deduced from the response to treatment with FCCP. Data are expressed
group; ANOVA (one-way) followed by post-hoc test with Bonferroni's comparisons.
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are also related to control of oxidative stress [27].
Overproduction of reactive oxygen species (ROS), a byproduct of
mitochondrial electron transport chain, has been implicated in acute
brain injuries such as ischemia [19]. PGC-1α is a master regulator of
scavenging enzymes including SOD2 andmay contribute to cell survival.
Our results showing that pre-exposure of n−3 fatty acid helped to
counteract the decreasing effect of TBI on SOD2 emphasizes the homeo-
static role of n−3 fatty acids in supporting antioxidant systems. An
increase in 4HNE levels after TBI with n−3 deﬁcient diet, suggests
that the deﬁciency of n−3 may predispose the brain towards lipid
peroxidation under challenging conditions. It is noteworthy that
polyunsaturated fatty acids (PUFAs) are highly susceptible to oxidative
damage such that lipid peroxidation could contribute to lower levels
of n−3. Our results showing that the n−3 deﬁciencywas not sufﬁcient
to alter 4HNE levels suggests that the n−3 deﬁcient diet was the main
factor for the reduction in n−3 levels. The negative correlation of 4HNE
with anxiety-like behavior suggests that the lipid peroxides (LPOs)may
inﬂuence the outcome of anxiety-like behavior.
4.3. The intermediate action of BDNF signaling on energy metabolism
and plasticity
There are several indications that BDNF works at the interface of
metabolism and synaptic plasticity such as by interacting with metabolic
molecules [12], inﬂuencingmitochondrial energymanagement efﬁciency
[28], and altering glucose utilization in neurons [29]. To explore a possible
association between energy homeostasis and synaptic plasticity and
behavior, we assessed the effects of our interventions on BDNF signaling.
We found that TBI reduced the levels of BDNF related systems, such as its
receptor TrkB, and its downstream effector CREB, only in the n−3 deﬁ-
cient rats. CREB works under BDNF regulation to modulate synaptic
plasticity and anxiety [30]. Our results showing that changes in CREB
phosphorylation are in proportion to PGC-1α levels, together with
reports that CREB is a potent activator of PGC-1α levels [31], emphasize
the double function of CREB as a synaptic activator and mitochondrial
biogenesis modulator. In addition, CREB has also been reported to regu-
late NPY [32] and BDNF [33] suggesting that the circuit BDNF–CREB–
NPYmayparticipate in the regulation of anxiety-like behavior. The overall
results imply that the n−3 deﬁciency may exacerbate the energy crisis
occurring after TBI, thereby impacting synaptic plasticity and mental
health.
We used the well-established ability of the BDNF receptor agonist
7,8-DHF to stimulate TrkB signaling in cultured cells. According to our
results, 7,8-DHF stimulated the actions of key elements in the BDNF
signaling cascade such as TrkB and CREB. In turn, the alteration in
BDNF signaling had the ability to upregulate PGC-1α, as reﬂected by
the elevated cellular expression of PGC-1α and CREB after 7,8-DHF
treatment. CREB is an important molecule in BDNF–TrkB signaling,
which converges pathways regulating synaptic activity and anxiety
[30]. This implies that the effects of 7,8-DHF on increasing CREB activa-
tionmay be signiﬁcant formodulation of synaptic plasticity. BDNF–TrkB
signaling acts through CREB to regulate PGC-1α [31], and this interac-
tion is also supported by the results from in vivo experiments showing
that levels of PGC-1α change in proportion to levels of CREB activation.
The association between CREB and PGC-1α is also reﬂected at the cellu-
lar level as to CREB and PGC-1α immunostainingwas co-localized in our
in vitro studies. The ability of BDNF tomodulate PGC-1α can be essential
for the brain operation under the domain of metabolism, as PGC-1α is a
master regulator of several important transcription factors in the mito-
chondria with the potential to affect a wide range of cellular functions.
According to our results, the increased levels of PGC-1α after 7,8-DHF
treatment indicates that the activation of BDNF–TrkB signaling recruits
metabolic modulators. A potential action of BDNF–TrkB signaling on
mitochondrial bioenergetics is supported by the results showing that
7,8-DHF increased mitochondrial respiration capacity.4.4. Metabolic homeostasis and neuropsychiatric disorders
It is suspected that mitochondrial dysfunction predisposes the brain
to neuropsychiatric abnormalities such as anxiety and depression
[34,35]; however, how metabolic signals affect behavior has remained
elusive. Reduced levels of NPY have been reported to be associated
with anxiety and depression-like behavior [22]. In turn, NPY has also
been related to metabolism as evidenced by its effects on insulin [36],
glucose homeostasis [37], and energy balance [38]. Our ﬁndings show-
ing that time spent in the open arms varied in proportion to the levels
of NPY1R, BDNF, PGC-1α, and in turn PGC-1α varied in proportion to
levels of CREB activation, appear to reﬂect an association between
energy homeostasis and behavior. Given the discussed roles of BDNF
on metabolism and plasticity, it is noteworthy that BDNF signaling has
important implications for thepathophysiology of several neuropsycho-
logical disorders such as anxiety [21] and depression [39]. Therefore, our
results showing that TBI reduced BDNF and its signaling molecules as
well as elevated anxiety-like behavior, evoke the capacity of TBI to
increase vulnerability to psychiatric disorders.4.5. Metabolic programming as a modulator of adult brain plasticity
The concept of “Metabolic Programming” refers to an adaptive pro-
cess whereby nutrition and other environmental factors during early
life can impact adult health by altering elements related to control of
cell metabolism. In compliance with this concept, our results provide
an indication for the involvement of critical molecules that regulate
energymetabolism onmechanisms that control brain plasticity. In addi-
tion, the results showing that the detrimental effects of TBI were
observed only under n−3 deﬁciency emphasize the power of n−3 to
protect the brain against challenges during adulthood. It is noteworthy
that fatty acids such as n−6 and n−9 may inﬂuence the functions of
n−3 fatty acids [40,41]. In spite of the beneﬁcial actions of n−3 fatty
acids, studies suggest that the n−3 supplementation during pregnancy
is not effective to lower the postpartum depression levels in mothers
and cognitive improvement in their children [42,43]. Therefore, further
studies are required to establish how diet provided on speciﬁc periods
of brain development can affect adult brain plasticity.
In summary, our results show that TBI disturbs pathways associated
with energy homeostasis and synaptic plasticity. Long-term dietary
n−3 inﬂuences the capacity of the brain to resist the effects of TBI
incurred during adult life. This action of n−3 was associated with key
molecular events ofmitochondrial bioenergetics, and synaptic plasticity
in the brain, and had implications for anxiety-like behavior (Fig. 8).
Further studies are required to determine the involvement of energy
metabolites, which could provide a more direct index of energy metab-
olism. In addition, the results of the BDNF receptor activation indicate a
potential mechanism by which synaptic plasticity is regulated in
conjunction with mitochondrial function. The overall results provide
insight to understand how metabolic and plasticity signals interact
with each other, and how the product of this interaction inﬂuences
long-term neuronal resilience against neurological and psychiatric
disorders.Disclosure/conﬂict of interest
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Fig. 8. Proposed mechanism by which traumatic brain injury (TBI) leads to disruption of brain energy metabolism with subsequent effects on cognitive performance. Dietary n−3 fatty
acid deﬁciency during early life may act as a vulnerability factor for the outcome of TBI. TBI and dietary n−3 fatty acid alter NPY1 and TrkB receptor signaling, thereby affecting the
co-transcriptional regulator PGC-1α via CREB. BDNF–TrkB signaling plays a pivotal action onmitochondrial bioenergetics throughmetabolic activators such as PGC-1α. PGC-1α activates
important transcription factors, including nuclear respiratory factors (NRFs). In turn, NRFs activate themitochondrial transcription factor A (TFAM), responsible for stimulatingmitochondrial
DNA (mtDNA) transcription, andmitochondrial proliferation. Trancription ofmitochondrial genes leads to the synthesis of mitochondrial proteins including cytochrome c oxidase (COII)
and superoxide dismutase (SOD2). COII regulates oxidative phosphorylation (OXPHOS) responsible for ATP production in mitochondria. Reactive oxygen species (ROS), a byproduct of
mitochondrial electron transport chain, stimulates the activation of PGC-1α signaling pathway which in turn upregulates the mitochondrial antioxidant protein SOD2. Adenosine
monophosphate-activated protein kinase (AMPK) helps to maintain the AMPK/ATP ratio, which is achieved, in part via activation of PGC-1α. These alterations in energy homeostasis
are important for maintaining neuronal functions and synaptic plasticity via CREB. The interplay between energymanagement and plasticity systems appears crucial for themaintenance
of neuronal function and neurological health.
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